SCHEMBL18685142

SCHEMBL18685142

CC(C)CSc1cc(Cl)ccc1CNC(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.43
CYP1A2 P05177 3/20 0.37
CYP2C19 P33261 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2D6 P10635 2/20 0.37
POLB P06746 1/20 0.36
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
METAP2 P50579 1/20 0.34
METAP1 P53582 1/20 0.34
KCNH2 Q12809 2/20 0.33
OPRL1 P41146 1/20 0.33
IDO1 P14902 1/20 0.33
TRPV4 Q9HBA0 1/20 0.32
MAPK1 P28482 1/20 0.32
KDM4E B2RXH2 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15983858 0.86 SLC6A4 (0.44) ROCK2KCNH2HTR2ASLC6A4
SCHEMBL18685141 0.85 ROCK2 (0.43) ROCK2CYP1A2CYP2C19MEN1KMT2A
SCHEMBL18685140 0.80 ROCK2 (0.39) ROCK2CYP1A2CYP2C19CYP3A4CYP2C9
SCHEMBL2647752 0.75 MEN1 (0.57) CYP1A2CYP2C19MEN1KMT2ACYP3A4
SCHEMBL19862553 0.72 CXCR3 (0.43) CYP1A2CYP2C19MEN1KMT2ACYP3A4
SCHEMBL14438275 0.72 MEN1 (0.43) CYP1A2CYP2C19MEN1KMT2ACYP3A4
SCHEMBL25453552 0.71 MEN1 (0.43) CYP1A2CYP2C19MEN1KMT2ACYP3A4
SCHEMBL21346321 0.70 KCNH2 (0.41) CYP1A2CYP2C19MEN1KMT2ACYP3A4
SCHEMBL21345583 0.67 LMNA (0.47) CYP1A2MEN1KMT2ACYP2D6KCNH2
SCHEMBL22885900 0.64 PDCD1LG2 (0.37) CYP1A2CYP2C19MEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2961745-B1 PHENYLPYRAZOLE DERIVATIVES AS POTENT ROCK1 AND ROCK2 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-03-29 EP disclosed